INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 45h ago
HOUSE PTR5h ago
SEC 13F5h ago
ROBINHOOD CHAIN5h ago
SEC FORM 4/Tax withholdingVerified data

Ding Xia reported USNA

Director · USANA HEALTH SCIENCES INC · Common Stock

Side
F
Value
$8,770
Shares
604
Price
$14.52
Executed
Oct 22, 2026
Disclosed
Oct 23, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Oct 22 executedOct 23, 2026 disclosed

USNA · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
13/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Tax withholding — administrative, little informational value

  • Relative size+5 / 25

$9K reported value · 6.9% of prior position

  • Filing timing0 / 15

    Disclosed 1 business day after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

  • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · USNA

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    13
    WJ
    Winssinger Frederic JDirector
    USNAUSANA HEALTH SCIENCES INC
    Option exercise
    M—
    1,632 sh
    Oct 22, 2026Oct 23, 2026
    traded Oct 22, 2026
    +1dSEC FORM 4

    Evidence

    21
    DX
    Ding XiaDirector
    USNAUSANA HEALTH SCIENCES INC
    Option exercise
    M—
    1,632 sh
    Oct 22, 2026Oct 23, 2026
    traded Oct 22, 2026
    +1dSEC FORM 4

    Evidence

    21
    PP
    Pelosi PeggieDirector
    USNAUSANA HEALTH SCIENCES INC
    Option exercise
    M—
    1,632 sh
    Oct 22, 2026Oct 23, 2026
    traded Oct 22, 2026
    +1dSEC FORM 4

    Evidence

    13
    NS
    Nixon J ScottDirector
    USNAUSANA HEALTH SCIENCES INC
    Option exercise
    M—
    1,632 sh
    Oct 22, 2026Oct 23, 2026
    traded Oct 22, 2026
    +1dSEC FORM 4

    Evidence

    21
    WJ
    Winssinger Frederic JDirector
    USNAUSANA HEALTH SCIENCES INC
    Option exercise
    M—
    1,632 sh
    Oct 22, 2026Oct 23, 2026
    traded Oct 22, 2026
    +1dSEC FORM 4

    Evidence

    17
    PP
    Pelosi PeggieDirector
    USNAUSANA HEALTH SCIENCES INC
    Option exercise
    M—
    1,632 sh
    Oct 22, 2026Oct 23, 2026
    traded Oct 22, 2026
    +1dSEC FORM 4

    Evidence

    21
    NS
    Nixon J ScottDirector
    USNAUSANA HEALTH SCIENCES INC
    Option exercise
    M—
    1,632 sh
    Oct 22, 2026Oct 23, 2026
    traded Oct 22, 2026
    +1dSEC FORM 4

    Evidence

    13
    PP
    Pelosi PeggieDirector
    USNAUSANA HEALTH SCIENCES INC
    Tax withholding
    F$14K
    935 sh
    Oct 22, 2026Oct 23, 2026
    traded Oct 22, 2026
    +1dSEC FORM 4

    Evidence

    13
    DX
    Ding XiaDirector
    USNAUSANA HEALTH SCIENCES INC
    Option exercise
    M—
    1,632 sh
    Oct 22, 2026Oct 23, 2026
    traded Oct 22, 2026
    +1dSEC FORM 4

    Evidence

    13
    FT
    Fleming John TurmanDirector
    USNAUSANA HEALTH SCIENCES INC
    Option exercise
    M—
    1,632 sh
    Oct 22, 2026Oct 23, 2026
    traded Oct 22, 2026
    +1dSEC FORM 4

    Evidence

    17
    FT
    Fleming John TurmanDirector
    USNAUSANA HEALTH SCIENCES INC
    Option exercise
    M—
    1,632 sh
    Oct 22, 2026Oct 23, 2026
    traded Oct 22, 2026
    +1dSEC FORM 4

    Evidence

    29
    FT
    Fleming John TurmanDirector
    USNAUSANA HEALTH SCIENCES INC
    Open-market sale
    SELL$44K
    2,450 sh
    Jun 1, 2026Jun 1, 2026
    traded Jun 1, 2026
    +0dSEC FORM 4

    Evidence

    9
    DX
    Ding XiaDirector
    USNAUSANA HEALTH SCIENCES INC
    Grant or award
    A—
    6,527 sh
    May 7, 2026May 11, 2026
    traded May 7, 2026
    +4dSEC FORM 4

    Evidence

    9
    FT
    Fleming John TurmanDirector
    USNAUSANA HEALTH SCIENCES INC
    Grant or award
    A—
    6,527 sh
    May 7, 2026May 11, 2026
    traded May 7, 2026
    +4dSEC FORM 4

    Evidence

    9
    PP
    Pelosi PeggieDirector
    USNAUSANA HEALTH SCIENCES INC
    Option exercise
    M—
    1,057 sh
    Apr 23, 2026Apr 27, 2026
    traded Apr 23, 2026
    +4dSEC FORM 4

    Evidence

    13
    FT
    Fleming John TurmanDirector
    USNAUSANA HEALTH SCIENCES INC
    Option exercise
    M—
    1,057 sh
    Apr 23, 2026Apr 27, 2026
    traded Apr 23, 2026
    +4dSEC FORM 4

    Evidence

    9
    FT
    Fleming John TurmanDirector
    USNAUSANA HEALTH SCIENCES INC
    Option exercise
    M—
    1,057 sh
    Apr 23, 2026Apr 27, 2026
    traded Apr 23, 2026
    +4dSEC FORM 4

    Evidence

    9
    NS
    Nixon J ScottDirector
    USNAUSANA HEALTH SCIENCES INC
    Option exercise
    M—
    1,057 sh
    Apr 23, 2026Apr 27, 2026
    traded Apr 23, 2026
    +4dSEC FORM 4

    Evidence

    9
    DX
    Ding XiaDirector
    USNAUSANA HEALTH SCIENCES INC
    Option exercise
    M—
    1,057 sh
    Apr 23, 2026Apr 27, 2026
    traded Apr 23, 2026
    +4dSEC FORM 4

    Evidence

    17
    PP
    Pelosi PeggieDirector
    USNAUSANA HEALTH SCIENCES INC
    Option exercise
    M—
    1,057 sh
    Apr 23, 2026Apr 27, 2026
    traded Apr 23, 2026
    +4dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001889687-26-000008
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Oct 22, 2026
    Published
    Oct 23, 2026
    Ingested by INSIDER
    Nov 5, 02:09 UTC
    Last re-read
    Nov 5, 02:09 UTC

    Extracted facts

    Filer
    Ding Xia
    Role
    Director
    Transaction
    Tax withholdingAs filed: “F”
    Asset
    USANA HEALTH SCIENCES INC
    Ticker
    USNA
    Shares
    604
    Price per share
    $14.52
    Value
    $8,770
    Execution date (reported)
    Oct 22, 2026
    Owned after transaction
    9,306 shares
    Days from execution to publication
    1

    Calculation

    Value = shares × reported price per share

    • Shares: 604
    • Price: $14.52

    = $8,770

    What this establishes

    Ding Xia filed this Form 4 reporting a tax withholding of USNA on Oct 22, 2026. It became public on Oct 23, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director
    Ding Xiacik:0001889687
    Issuer
    USANA HEALTH SCIENCES INCcik:0000896264

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.